Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

response to cyclophosphamide

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Macrophage Activation Syndrome as the Initial Manifestation of Severe Juvenile Onset Systemic Lupus Erythematosus. Favorable Response to Cyclophosphamide
The macrophage activation syndrome is a rare but potentially fatal complication of patients with autoimmune rheumatic diseases… Expand
2014
2014
A Case of Localized Papular Mucinosis Showing Excellent Response to Cyclophosphamide
2013
2013
The GSTP1 105Val Allele Increases Breast Cancer Risk and Aggressiveness but Enhances Response to Cyclophosphamide Chemotherapy in North China
The glutathione-S-transferase (GST) family contributes to the inactivation of various toxic compounds formed as secondary… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
2013
2013
Treatment-Induced Acute Leukaemia after Major Response to Cyclophosphamide-Based Metronomic Chemotherapy in Refractory Heavily Pre-Treated Prostate Cancer
Background: metronomic chemotherapy is based on antiangiogenic and immunologic mechanisms obtained by the administration of… Expand
  • figure 1
  • figure 2
  • figure 3
2012
2012
Which CYP2B6 Variants Have Functional Consequences for Cyclophosphamide Bioactivation?
We read with interest the recent publications by [Ariyoshi et al. (2011)][1] and [Raccor et al. (2011)][2]. The role of a number… Expand
  • table 1
2010
2010
Correlation Of BAL Interleukin-16 With SCLERODERMA Interstitial Lung Disease ACTIVITY AND RESPONSE TO CYCLOPHOSPHAMIDE
2008
2008
Nitrergic Response TO Cyclophosphamide Treatment in Blood and Bone Marrow
Daily intraperitoneal injection of cyclophosphamide (CPA) (50 mg∙kg-1 of body weight) for 5 days resulted in reduced levels of… Expand
2008
2008
Neural Progenitor Cell-mediated Delivery of Interferon Beta Improves Neuroblastoma Response to Cyclophosphamide
BackgroundWe have shown that continuous systemic delivery of interferon beta (IFN-β) remodels dysfunctional tumor vasculature… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2003
2003
A mouse-based strategy for cyclophosphamide pharmacogenomic discovery.
Genome-wide mapping approaches are needed to more fully understand the genetic basis of chemotherapy response. Because of… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
1998
1998
Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour.
When cyclophosphamide (CY) (100-120 mg kg(-1)) was administered intravenously (i.v.) to normal F-344 rats, oliguria occurred over… Expand
  • figure 1
  • figure 2
  • table 2
  • table 1
  • figure 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE